FMI Reveals Biomarker-driven Breakthroughs! Companion Diagnostic Tests Unlock Precision Treatment with PARP Inhibitors. The Industry Projected to surpass US$ 16,153.50 million by 2034
20 mars 2024 10h30 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, March 20, 2024 (GLOBE NEWSWIRE) -- The PARP inhibitor market is anticipated to be worth US$ 6,279.90 million in 2024. The adoption of PARP inhibitors is likely to rise at a CAGR of...
PARP Inhibitor Market to Surpass USD 67.0 Billion by 2034, with 18.30% CAGR and Redefining Cancer Treatment Landscape - By PMI
27 févr. 2024 14h30 HE
|
PMI
Covina, Feb. 27, 2024 (GLOBE NEWSWIRE) -- “According to the recent research study, the PARP Inhibitor Market size was valued at about USD 12.5 Billion in 2024 and expected to grow at CAGR of 18.30%...
Global PARP Inhibitor Market To Grow At A CAGR Of 27.4% Due To Expanding Role Of PARP Inhibitors In Cancer Treatment
22 juil. 2020 08h30 HE
|
Quince Market Insights
Pune, India, July 22, 2020 (GLOBE NEWSWIRE) -- Global PARP Inhibitor Market was valued at USD 924 million in 2018 and predicted to grow at an exponential CAGR of 27.4% during the forecast period....